TRY 0.89
(-1.11%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Cash Flow | 110.52 Million | -1.51 Billion | 288.91 Million | 55.55 Million | -87.3 Million |
Net Income | -743.98 Million | -663.01 Million | -231.02 Million | -230.87 Million | -11.69 Million |
Depreciation & Amortization | -420.34 Million | -487.92 Million | 104.25 Million | 49.48 Million | 43.57 Million |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - |
Change in working capital | -10.34 Million | -1.74 Billion | 397.69 Million | 40.96 Million | -249.94 Million |
Other non-cash items | 1.5 Billion | 2.04 Billion | -7.02 Million | 193.41 Million | 125.15 Million |
Investing Cash Flow | 688.88 Million | 774.43 Million | -267.14 Million | -221.68 Million | -440.89 Thousand |
Investments in PPE | -380.34 Million | -155.47 Million | -288.8 Million | -147.83 Million | -36.93 Million |
Acquisitions | - | - | - | -160 Million | - |
Investment purchases | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - |
Other Investing Activities | 688.88 Million | - | - | - | - |
Financing Cash Flow | -809.7 Million | 712.53 Million | -60.79 Million | 224 Million | 84.94 Million |
Debt repayment | -1.32 Billion | -1.01 Billion | -60.79 Million | -151.23 Million | -208.3 Million |
Dividends payments | - | - | - | - | - |
Common Stock Repurchased | -2.01 Billion | - | - | - | - |
Common Stock Issuance | - | - | - | 265.98 Million | - |
Other Financing Activities | -117.68 Million | - | - | 4.08 Million | 2.2 Million |
Accounts receivables | 129.57 Million | - | - | - | - |
Accounts payables | - | - | - | - | - |
Inventory | -58.01 Million | 57.28 Million | -26.38 Million | -4.71 Million | -2.11 Million |
Other working capital | -81.9 Million | - | - | - | - |
Cash at beginning of period | 23.48 Million | 52.63 Million | 60.51 Million | 2.63 Million | 5.43 Million |
Cash at end of period | 13.19 Million | 23.48 Million | 21.49 Million | 60.51 Million | 2.63 Million |
Capital Expenditure | -380.34 Million | -155.47 Million | -288.8 Million | -147.83 Million | -36.93 Million |
Effect of forex changes on cash | - | - | - | - | - |
Net cash flow / Change in cash | -10.29 Million | -29.14 Million | -39.02 Million | 57.87 Million | -2.79 Million |
Free Cash Flow | -269.82 Million | -1.67 Billion | 108 Thousand | -92.28 Million | -124.24 Million |
Breakdown | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 521.57 Million | -743.98 Million | -411.75 Million | -404.53 Million | -449.27 Million | -663.01 Million |
Depreciation & Amortization | -665.52 Million | -420.34 Million | 91.45 Million | 103.42 Million | 50.3 Million | -487.92 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 58.76 Million | -10.34 Million | -1.01 Billion | 401.96 Million | 542.8 Million | -1.74 Billion |
Other non-cash items | 1.28 Billion | 1.5 Billion | - | 102.14 Million | 9.94 Million | 2.04 Billion |
Investing Cash Flow | 1.31 Billion | 688.88 Million | 9.88 Million | -350.99 Million | -282.18 Million | 774.43 Million |
Investments in PPE | - | -380.34 Million | 321.9 Million | -727.7 Million | -282.24 Million | -155.47 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 1.31 Billion | - | - | - | - | - |
Financing Cash Flow | -2.52 Billion | -809.7 Million | 1.45 Billion | 268.75 Million | -17 Million | 712.53 Million |
Debt repayment | -1.62 Billion | -1.32 Billion | -187.32 Million | -107.44 Million | -7.52 Million | -1.01 Billion |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | -2.01 Billion | - | - | - | - |
Common Stock Issuance | - | - | 1.51 Billion | - | - | - |
Other Financing Activities | -117.68 Million | - | - | - | - | - |
Accounts receivables | 1.1 Billion | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | -33.1 Million | -58.01 Million | 16.49 Million | -1.75 Million | -39.64 Million | 57.28 Million |
Other working capital | -1.01 Billion | - | - | - | - | - |
Cash at beginning of period | 16.36 Million | 23.48 Million | 21.82 Million | 29.76 Million | 13.38 Million | 52.63 Million |
Cash at end of period | 13.19 Million | 13.19 Million | 16.36 Million | 21.82 Million | 29.76 Million | 23.48 Million |
Capital Expenditure | - | -380.34 Million | 321.9 Million | -727.7 Million | -282.24 Million | -155.47 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -3.17 Million | -10.29 Million | -5.45 Million | -7.94 Million | 16.37 Million | -29.14 Million |
Free Cash Flow | 1.19 Billion | -269.82 Million | -1.15 Billion | -653.4 Million | 33.31 Million | -1.67 Billion |
AHL-PD
IRLAB-A
CDNAF
SPR
6622
CRI